EP4065111 - POTENT AND SELECTIVE AZAINDOLE INHIBITORS OF CDK8 AND CDK19 [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 02.09.2022 Database last updated on 31.08.2024 | |
Former | The international publication has been made Status updated on 04.06.2021 | Most recent event Tooltip | 01.03.2024 | Amendment by applicant | Applicant(s) | For all designated states Dana-Farber Cancer Institute, Inc. 450 Brookline Avenue Boston, Massachusetts 02215 / US | [2022/40] | Inventor(s) | 01 /
GRAY, Nathanael S. 26 Greenview Avenue Boston, Massachusetts 02130 / US | 02 /
HATCHER, John M. 2 Glover Court BOSTON, Massachusetts 02127 / US | 03 /
SREEVATSAN, Prasanna 275 Main Street, Apt. 702 Watertown, Massachusetts 02472 / US | [2022/40] | Representative(s) | Heller, Benjamin Henry, et al Kilburn & Strode LLP Lacon London 84 Theobalds Road London WC1X 8NL / GB | [2022/40] | Application number, filing date | 20893666.6 | 25.11.2020 | [2022/40] | WO2020US62264 | Priority number, date | US201962940632P | 26.11.2019 Original published format: US 201962940632 P | [2022/40] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2021108581 | Date: | 03.06.2021 | Language: | EN | [2021/22] | Type: | A1 Application with search report | No.: | EP4065111 | Date: | 05.10.2022 | Language: | EN | The application published by WIPO in one of the EPO official languages on 03.06.2021 takes the place of the publication of the European patent application. | [2022/40] | Search report(s) | International search report - published on: | US | 03.06.2021 | (Supplementary) European search report - dispatched on: | EP | 18.08.2023 | Classification | IPC: | C07D519/00, A61K31/437, A61P25/28, A61P35/00 | [2023/38] | CPC: |
C07D519/00 (EP,US);
A61P25/28 (EP);
A61P35/00 (EP);
C07D471/04 (US);
C07D487/04 (US);
C07D495/04 (US)
|
Former IPC [2022/40] | A61K31/437, C07D471/04, C07D401/14 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2022/40] | Title | German: | HOCHWIRKSAME UND SELEKTIVE AZAINDOLINHIBITOREN VON CDK8 UND CDK19 | [2022/40] | English: | POTENT AND SELECTIVE AZAINDOLE INHIBITORS OF CDK8 AND CDK19 | [2022/40] | French: | INHIBITEURS AZAINDOLIQUES PUISSANTS ET SÉLECTIFS DE CDK8 ET CDK19 | [2022/40] | Entry into regional phase | 20.06.2022 | National basic fee paid | 20.06.2022 | Search fee paid | 20.06.2022 | Designation fee(s) paid | 20.06.2022 | Examination fee paid | Examination procedure | 20.06.2022 | Examination requested [2022/40] | 29.02.2024 | Amendment by applicant (claims and/or description) | 29.02.2024 | Date on which the examining division has become responsible | Fees paid | Renewal fee | 28.11.2022 | Renewal fee patent year 03 | 27.11.2023 | Renewal fee patent year 04 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [A] - AURÉLIE MALLINGER ET AL, "Discovery of Potent, Selective, and Orally Bioavailable Small-Molecule Modulators of the Mediator Complex-Associated Kinases CDK8 and CDK19", JOURNAL OF MEDICINAL CHEMISTRY, US, (20160211), vol. 59, no. 3, doi:10.1021/acs.jmedchem.5b01685, ISSN 0022-2623, pages 1078 - 1101, XP055336343 [A] 1-15 * table 5; compound 3 * DOI: http://dx.doi.org/10.1021/acs.jmedchem.5b01685 | International search | [Y]US2011195951 (GRACZYK PIOTR PAWEL [GB], et al) [Y] 16 * abstract; para [0072] *; | [A]US2011201599 (BAHCECI SULEYMAN [US], et al) [A] 1-3, 5-8, 14-16; 18 * ENTIRE DOCUMENT *; | [A]US2017027956 (HOPKINS BRIAN T [US], et al) [A] 1-3, 5-8, 14-16; 18* ENTIRE DOCUMENT *; | [XY]US2018215763 (WU GUOXIAN [US], et al) [X] 1-3; 5-8, 14; 15; 18 * para [0002]; pg. 136, Table 1; pg. 151, Table 1 * [Y] 16 |